Cargando…

Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer

Ovarian cancer treatment remains a challenge and targeting cancer stem cells presents a promising strategy. Niclosamide is an “old” antihelminthic drug that uncouples mitochondria of intestinal parasites. Although recent studies demonstrated that niclosamide could be a potential anticancer agent, it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Chi-Kang, Bai, Meng-Yi, Hu, Teh-Min, Wang, Yu-Chi, Chao, Tai-Kuang, Weng, Shao-Ju, Huang, Rui-Lan, Su, Po-Hsuan, Lai, Hung-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891020/ https://www.ncbi.nlm.nih.gov/pubmed/26848771 http://dx.doi.org/10.18632/oncotarget.7113

Ejemplares similares

Niclosamide: Beyond an antihelminthic drug
por: Chen, Wei, et al.
Publicado: (2018)

Antihelminthic niclosamide modulates dendritic cells activation and function
por: Wu, Chieh-Shan, et al.
Publicado: (2014)

The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo
por: Zhou, Jingfeng, et al.
Publicado: (2017)

The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum
por: Zhou, Jingfeng, et al.
Publicado: (2020)

Potent Inhibition of Macropinocytosis by Niclosamide in Cancer Cells: A Novel Mechanism for the Anticancer Efficacy for the Antihelminthic
por: Sennoune, Souad R., et al.
Publicado: (2023)

Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells
por: Pan, Jing-Xuan, et al.
Publicado: (2012)

An Integrated Bioinformatics Analysis Repurposes an Antihelminthic Drug Niclosamide for Treating HMGA2-Overexpressing Human Colorectal Cancer
por: Leung, Stephen Wan, et al.
Publicado: (2019)

Drug Screening Identifies Niclosamide as an Inhibitor of Breast Cancer Stem-Like Cells
por: Wang, Yu-Chi, et al.
Publicado: (2013)

The Antihelminthic Niclosamide Inhibits Cancer Stemness, Extracellular Matrix Remodeling, and Metastasis through Dysregulation of the Nuclear β-catenin/c-Myc axis in OSCC
por: Wang, Lin-Hong, et al.
Publicado: (2018)

Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer
por: Chao, Tai-Kuang, et al.
Publicado: (2017)

Antihelminthics in helminth‐endemic areas: effects on HIV disease progression
por: Means, Arianna Rubin, et al.
Publicado: (2016)

Niclosamide inhibits ovarian carcinoma growth by interrupting cellular bioenergetics
por: Shangguan, Fugen, et al.
Publicado: (2020)

Niclosamide (NA) overcomes cisplatin resistance in human ovarian cancer
por: Huang, Linjuan, et al.
Publicado: (2023)

Immunological Consequences of Antihelminthic Treatment in Preschool Children Exposed to Urogenital Schistosome Infection
por: Rujeni, Nadine, et al.
Publicado: (2013)

Recent large-scale philophthalmosis outbreak in Portugal: inefficacy of common antihelminthic agents
por: Heneberg, Petr, et al.
Publicado: (2022)

The antihelminth drug rafoxanide reverses chromosomal-mediated colistin-resistance in Klebsiella pneumoniae
por: Han, Rongjia, et al.
Publicado: (2023)

Ovarian cancer stem-like cells with induced translineage-differentiation capacity and are suppressed by alkaline phosphatase inhibitor
por: Liu, Kuei-Chun, et al.
Publicado: (2013)

Antihelminthic Activity of Lophira Lanceolata on Heligmosomoides polygyrus Using an Automated High-Throughput Method
por: Cédric, Yamssi, et al.
Publicado: (2023)

Nutraceutical-Based Nanoformulations for Breast and Ovarian Cancer Treatment
por: Serini, Simona, et al.
Publicado: (2022)

The magic bullet: Niclosamide
por: Jiang, Haowen, et al.
Publicado: (2022)

Niclosamide ethanolamine ameliorates diabetes-related muscle wasting by inhibiting autophagy
por: Cai, Yuchun, et al.
Publicado: (2021)

Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission
por: Wang, Yu-Ming, et al.
Publicado: (2016)

In Vitro Antigenotoxic, Antihelminthic and Antioxidant Potentials Based on the Extracted Metabolites from Lichen, Candelariella vitellina
por: El-Garawani, Islam, et al.
Publicado: (2020)

Inflammasome-Independent Role for NLRP3 in Controlling Innate Antihelminth Immunity and Tissue Repair in the Lung
por: Chenery, Alistair L., et al.
Publicado: (2019)

The Simultaneous Inhibitory Effect of Niclosamide on RANKL-Induced Osteoclast Formation and Osteoblast Differentiation
por: Liu, Fei-Lan, et al.
Publicado: (2017)

Schistosoma haematobium Treatment in 1–5 Year Old Children: Safety and Efficacy of the Antihelminthic Drug Praziquantel
por: Mutapi, Francisca, et al.
Publicado: (2011)

Time‐dependent Modulation of Liver Lesion Development in Opisthorchis‐infected Syrian Hamster by an Antihelminthic Drug, Praziquantel
por: Thamavit, Witaya, et al.
Publicado: (1993)

The Antihelminthic Drug, Mebendazole, Induces Apoptosis in Adult T-Cell Leukemia/Lymphoma Cancer Cells: In-Vitro Trial
por: Maali, Amirhosein, et al.
Publicado: (2020)

Ovarian cancer detection by DNA methylation in cervical scrapings
por: Wu, Tzu-I, et al.
Publicado: (2019)

Binding interactions of niclosamide with serum proteins
por: Maltas, Esra
Publicado: (2014)

Niclosamide for Covid-19: bridging the gap
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

Antitumor effect and metabonomics of niclosamide micelles
por: Hang, Jiarong, et al.
Publicado: (2022)

Synthesis and biological evaluation of niclosamide PROTACs
por: Munoz, Erick, et al.
Publicado: (2022)

Repurposing niclosamide for the treatment of neurological disorders
por: Apolloni, Savina, et al.
Publicado: (2023)

Desolvation Processes in Channel Solvates of Niclosamide
por: Mann, Jen E., et al.
Publicado: (2023)

The antiparasitic drug niclosamide inhibits dengue virus infection by interfering with endosomal acidification independent of mTOR
por: Kao, Jo-Chi, et al.
Publicado: (2018)

Design, synthesis and biological evaluations of niclosamide analogues against SARS-CoV-2
por: Juang, Yu-Pu, et al.
Publicado: (2022)

Niclosamide Is Active In Vitro against Mycetoma Pathogens
por: Mahmoud, Abdelhalim B., et al.
Publicado: (2021)

Niclosamide—A promising treatment for COVID‐19
por: Singh, Shivani, et al.
Publicado: (2022)

TEM1-targeting PEGylated PLGA shikonin nanoformulation for immunomodulation and eradication of ovarian cancer
por: Matthaiou, Efthymia-Iliana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ars5u3vuvaaqih7rmfop1fr43j